wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33713947-440FDDFB-D73B-4BE5-805E-A32F4F4E3A81
Q33713947-440FDDFB-D73B-4BE5-805E-A32F4F4E3A81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33713947-440FDDFB-D73B-4BE5-805E-A32F4F4E3A81
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways.
P2860
Q33713947-440FDDFB-D73B-4BE5-805E-A32F4F4E3A81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33713947-440FDDFB-D73B-4BE5-805E-A32F4F4E3A81
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0e0fb6cc3451e08e72f5f06e7ea9d2556d6fa0c
P2860
ECCO position statement: the use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD).